Search results
Author(s):
Gaetano Antonio Lanza
Added:
7 months ago
Author(s):
Gabriel Torres-Ruiz
,
Nuria Mallofré-Vila
,
Paola Rojas-Flores
,
et al
Added:
2 years ago
Author(s):
Yury Malyshev
Added:
1 year ago
AF Symposium 24 — Dr Yury Malyshev (Mount Sinai Hospital, US) joins us to discuss the findings from three studies focusing on the long-term effects of pulsed-field ablation (PFA) on coronary arteries.QuestionsWhat is known currently about the effect of PFA in Coronary Arteries? What is the importance of this topic?What was the study design and cohort?What are the key findings?Who are the take…
View more
Author(s):
Milind Y Desai
Added:
4 months ago
ESC Congress 2025 - ODYSSEY-HCM finds no improvements in patients with non-obstructive cardiomyopathy when treated with mavacamten.Dr Milind Desai (Cleveland Clinic, US) joins us to discuss findings from the ODYSSEY-HCM trial, evaluating the safety, tolerability, and efficacy of mavacamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy.The ODYSSEY-HCM study was a…
View more
Author(s):
Mackram F Eleid
Added:
2 months ago
Explore advanced strategies for preventing and managing LVOT obstruction in transcatheter mitral valve replacement with Dr Mackram EleidThis presentation, part of Women As One's comprehensive Structural Interventions track, examines of a 90-year-old patient with severe mitral annular calcification, heart failure with preserved ejection fraction, and significant basal septal hypertrophy. Dr Eleid…
View more
Author(s):
Ahmed Elamin
,
Mustafa Abdimalik
,
Mohanad Abdelrahim
,
et al
Added:
2 months ago
Author(s):
Johanna McChord
,
Astrid Hubert
,
Udo Sechtem
,
et al
Added:
1 year ago
Author(s):
William E Boden
,
Juan Carlos Kaski
,
C Noel Bairey Merz
,
et al
Added:
8 months ago
Author(s):
Armin Arbab-Zadeh
,
Michelle Graham
,
Hector M Garcia-Garcia
,
et al
Added:
4 months ago
Author(s):
Luca Testa
Added:
1 year ago
Dr Luca Testa (IRCCS Policlinico San Donato, IT) discusses the results of the XLIMIT Trial at the EuroPCR 2024 congress in Paris, France.In this video interview, Dr Testa explains the technology behind the XLIMUS® drug-eluting stent (Cardionovum®) and its benefits. He also reviews the XLIMIT Trial, detailing the study design, selection criteria and clinical outcomes.Specifically, the 6 to 9…
View more